Paper42850337PubMed
Copper-induced suppression of the PPARα-FABP1 axis sensitizes hepatocytes to ferroptosis in Wilson disease.
Li Y and 6 others. J Mol Med (Berl), 2026.
Cite this record
ConductScience Library. Copper-induced suppression of the PPARα-FABP1 axis sensitizes hepatocytes to ferroptosis in Wilson disease. Papers, record 42850337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42850337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Copper-induced suppression of the PPARα-FABP1 axis sensitizes hepatocytes to ferroptosis in Wilson disease.
- Journal
- J Mol Med (Berl)
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-11-05
Source PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| PPAR alpha | Major topic |
| Fatty Acid-Binding Proteins | Major topic |
| Hepatocytes | Major topic |
| Ferroptosis | Major topic |
| Copper | Major topic |
| Hepatolenticular Degeneration | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Lipid Peroxidation | |
| Signal Transduction | |
| Liver | |
| Male | |
| Mice, Knockout |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38928368 | Copper, Iron, Cadmium, and Arsenic, All Generated in the Universe: Elucidating Their Environmental Impact Risk on Human Health Including Clinical Liver Injury. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38928368 | PubMed |
| 2 | 32411316 | Copper Induces Oxidative Stress and Apoptosis in the Mouse Liver. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/32411316 | PubMed |
| 3 | 36472117 | Heavy Metals, Halogenated Hydrocarbons, Phthalates, Glyphosate, Cordycepin, Alcohol, Drugs, and Herbs, Assessed for Liver Injury and Mechanistic Steps. | Front Biosci (Landmark Ed) | 2022 | https://conductscience.org/library/papers/36472117 | PubMed |
| 4 | 31924743 | Metabolic dysregulation in the Atp7b-/- Wilson's disease mouse model. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/31924743 | PubMed |
| 5 | 19289416 | L-FABP directly interacts with PPARalpha in cultured primary hepatocytes. | J Lipid Res | 2009 | https://conductscience.org/library/papers/19289416 | PubMed |
| 6 | 30888116 | GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis. | Proteomics | 2019 | https://conductscience.org/library/papers/30888116 | PubMed |
| 7 | 36293069 | Aluminum, Arsenic, Beryllium, Cadmium, Chromium, Cobalt, Copper, Iron, Lead, Mercury, Molybdenum, Nickel, Platinum, Thallium, Titanium, Vanadium, and Zinc: Molecular Aspects in Experimental Liver Injury. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36293069 | PubMed |
| 8 | 40694956 | Gastric cancer adapts high lipid microenvironment via suppressing PPARG-FABP1 axis after arriving in the lymph node. | Redox Biol | 2025 | https://conductscience.org/library/papers/40694956 | PubMed |
| 9 | 31209199 | Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31209199 | PubMed |
| 10 | 20847941 | The Role of PPARα Activation in Liver and Muscle. | PPAR Res | 2010 | https://conductscience.org/library/papers/20847941 | PubMed |
| 11 | 32832193 | Lipid and energy metabolism in Wilson disease. | Liver Res | 2020 | https://conductscience.org/library/papers/32832193 | PubMed |
| 12 | 38731973 | Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38731973 | PubMed |
| 13 | 38072238 | Hepatic oxylipin profiles in mouse models of Wilson disease: New insights into early hepatic manifestations. | Biochim Biophys Acta Mol Cell Biol Lipids | 2024 | https://conductscience.org/library/papers/38072238 | PubMed |
| 14 | 32485807 | Oxylipin Profiles in Plasma of Patients with Wilson's Disease. | Metabolites | 2020 | https://conductscience.org/library/papers/32485807 | PubMed |
| 15 | 36147466 | Downregulation of PPARα mediates FABP1 expression, contributing to IgA nephropathy by stimulating ferroptosis in human mesangial cells. | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/36147466 | PubMed |
| 16 | 19474456 | Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity. | J Lipid Res | 2009 | https://conductscience.org/library/papers/19474456 | PubMed |
| 17 | 40089450 | EASL-ERN Clinical Practice Guidelines on Wilson's disease. | J Hepatol | 2025 | https://conductscience.org/library/papers/40089450 | PubMed |
| 18 | 37741465 | Therapeutic implications of impaired nuclear receptor function and dysregulated metabolism in Wilson's disease. | Pharmacol Ther | 2023 | https://conductscience.org/library/papers/37741465 | PubMed |
| 19 | 26241054 | Elevated copper impairs hepatic nuclear receptor function in Wilson's disease. | J Clin Invest | 2015 | https://conductscience.org/library/papers/26241054 | PubMed |
| 20 | 27842066 | Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. | Nat Chem Biol | 2017 | https://conductscience.org/library/papers/27842066 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42850337
GET https://conductscience.org/api/papers/v1/42850337/references?page=2